Huntington National Bank’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9 | Hold |
1
| – | – | ﹤0.01% | 3801 |
|
|
2025
Q4 | $9 | Hold |
1
| – | – | ﹤0.01% | 3716 |
|
|
2025
Q3 | $9 | Hold |
1
| – | – | ﹤0.01% | 3747 |
|
|
2025
Q2 | $9 | Hold |
1
| – | – | ﹤0.01% | 3747 |
|
|
2025
Q1 | $8 | Hold |
1
| – | – | ﹤0.01% | 3781 |
|
|
2024
Q4 | $5 | Hold |
1
| – | – | ﹤0.01% | 3894 |
|
|
2024
Q3 | $7 | Hold |
1
| – | – | ﹤0.01% | 3819 |
|
|
2024
Q2 | $11 | Sell |
1
-96
| -99% | -$1.23K | ﹤0.01% | 3655 |
|
|
2024
Q1 | $1.82K | Hold |
97
| – | – | ﹤0.01% | 2160 |
|
|
2023
Q4 | $2.1K | Hold |
97
| – | – | ﹤0.01% | 2064 |
|
|
2023
Q3 | $2K | Buy |
97
+96
| +9,600% | +$2.77K | ﹤0.01% | 2051 |
|
|
2023
Q2 | $47 | Hold |
1
| – | – | ﹤0.01% | 2672 |
|
|
2023
Q1 | $42 | Hold |
1
| – | – | ﹤0.01% | 2585 |
|
|
2022
Q4 | $38 | Hold |
1
| – | – | ﹤0.01% | 2511 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2344 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2368 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2321 |
|
|
2021
Q4 | $0 | Buy |
+1
| New | +$42 | ﹤0.01% | 2270 |
|
|
2021
Q3 | – | Sell |
-205
| Closed | -$12K | – | 2003 |
|
|
2021
Q2 | $12K | Buy |
205
+50
| +32% | +$3.53K | ﹤0.01% | 1416 |
|
|
2021
Q1 | $12K | Buy |
+155
| New | +$12.7K | ﹤0.01% | 1296 |
|
|
2020
Q1 | – | Sell |
-125
| Closed | -$9K | – | 1801 |
|
|
2019
Q4 | $9K | Buy |
+125
| New | +$15.4K | ﹤0.01% | 1428 |
|
|
2018
Q3 | – | Sell |
-15
| Closed | -$2K | – | 1852 |
|
|
2018
Q2 | $2K | Buy |
+15
| New | +$2.35K | ﹤0.01% | 1527 |
|
|
2016
Q4 | – | Sell |
-9
| Closed | – | – | 1499 |
|
|
2016
Q3 | $0 | Hold |
9
| – | – | ﹤0.01% | 1572 |
|
|
2016
Q2 | $0 | Sell |
9
-4
| -31% | -$133 | ﹤0.01% | 1643 |
|
|
2016
Q1 | $0 | Sell |
13
-205
| -94% | -$7.22K | ﹤0.01% | 1816 |
|
|
2015
Q4 | $13K | Buy |
218
+211
| +3,014% | +$10.5K | ﹤0.01% | 1327 |
|
|
2015
Q3 | $0 | Sell |
7
-6
| -46% | -$370 | ﹤0.01% | 1777 |
|
|
2015
Q2 | $0 | Hold |
13
| – | – | ﹤0.01% | 1822 |
|
|
2015
Q1 | $0 | Buy |
+13
| New | +$559 | ﹤0.01% | 1763 |
|
Huntington National Bank's SAGE Position: Q1 2026 in Review
Huntington National Bank held its Sage Therapeutics (SAGE) position steady in Q1 2026 at 1 share worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #3801.
Huntington National Bank first reported a position in SAGE in Q1 2015 and has held it in 29 quarters since. The position peaked at $13K in Q4 2015. 1 fund tracked by Wall St. Rank holds SAGE as of Q1 2026.
- Huntington National Bank held 1 share of Sage Therapeutics worth $9 as of Q1 2026.
- Huntington National Bank left its Sage Therapeutics share count unchanged in Q1 2026.
- Sage Therapeutics made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #3801 holding.
- Huntington National Bank first reported a position in Sage Therapeutics in Q1 2015 and has held it in 29 quarters since.
- Huntington National Bank's Sage Therapeutics position peaked at $13K in Q4 2015.
- 1 fund tracked by Wall St. Rank held Sage Therapeutics as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.